Back
Kazia Therapeutics 10K Form
Buy
67
KZIA
Kazia Therapeutics
Last Price:
5.77
Seasonality Move:
17.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2006-11-07 | 10Q | KZIA/Kazia Therapeutics Quarterly |
Receive KZIA News And Ratings
See the #1 stock for the next 7 days that we like better than KZIA
KZIA Financial Statistics
Sales & Book Value
| Annual Sales: | $1.51M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.01 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -6.66830 |
|---|---|
| Net Income (TTM): | $-17.58M |
| Gross Margin: | $1.58M |
| Return on Equity: | -1083.16% |
| Return on Assets: | -106.28% |
Kazia Therapeutics Earnings Forecast
Key Kazia Therapeutics Financial Ratios
- The Gross Profit Margin over the past 12 years for KZIA is 100.00%.
- The Selling, General & Administrative Expenses for KZIA have been equal to 587.65% of Gross Profit Margin.
- The Research & Development expenses have been 753.03% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Kazia Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KZIA |
| CUSIP: | 48669G |
| Website: | kaziatherapeutics.com |
Debt
| Debt-to-Equity Ratio: | -0.06 |
|---|---|
| Current Ratio: | 0.24 |
| Quick Ratio: | 0.07 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KZIA Technical Analysis vs Fundamental Analysis
Buy
67
Kazia Therapeutics (KZIA)
is a Buy
Is Kazia Therapeutics a Buy or a Sell?
-
Kazia Therapeutics stock is rated a Buy
The current Kazia Therapeutics [KZIA] share price is $5.76. The Score for KZIA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.